Search results for "Static"

showing 10 items of 1528 documents

Mass spectrometric identification of the amino donor and acceptor sites in a transglutaminase protein substrate secreted from rat seminal vesicles.

1991

Four different transglutaminase-modified forms of a protein secreted by the rat seminal vesicles (SV-IV) were synthesized in vitro and characterized. FAB maps of both the native protein and its derivatives, produced by the purified guinea pig liver enzyme in the presence or absence of the polyamine spermidine, were obtained by mass spectrometric analysis after proteolytic digestions. Two differently derivatized SV-IV molecular forms, both possessing only one glutamine residue out of two (Gln-86) cross-linked to endogenous lysine residues, were produced when spermidine was omitted from the reaction mixture: (i) an insoluble homopolymer in which Lys-2, -4, -59, -78, -79, and -80 were involved…

MaleTissue transglutaminaseSeminal Plasma ProteinsLysineGuinea PigsMolecular Sequence DataBiochemistryMass SpectrometrySubstrate SpecificityResidue (chemistry)chemistry.chemical_compoundAnimalsAmino Acid Sequencechemistry.chemical_classificationIsopeptide bondTransglutaminasesbiologyHydrolysisSeminal Plasma ProteinsProstatic Secretory ProteinsProteinsSeminal VesiclesRats Inbred StrainsRatsSpermidineSecretory proteinchemistryBiochemistryLiverbiology.proteinPolyamineChromatography LiquidBiochemistry
researchProduct

Dietary Habits in a Child Population in Relation to Caries Experience

2008

Sugar consumption in Spain has remained constant at around 80 g/day since the 1970s. Although intake as sugar has fallen considerably, to around 13.5 g/person/day, the intake in processed foods has risen. Meanwhile, caries prevalence is falling or stabilizing. This situation is common in developed countries, where the impact of diet on caries has altered, probably through greater use of fluoridated products. In the Valencia region, children habitually eat sugary foods and drinks and snacks that contain starches or sugars and starches. The present study analyzed the association between caries experience, quantified as the sum of the dfs and DMFS indices, and the consumption of cariogenic foo…

MaleToothbrushingCross-sectional studyPopulationCarbonated BeveragesCariogenic AgentsSugar consumptionDental CariesCandyFluoridesCheeseDietary SucroseEnvironmental healthDietary CarbohydratesHumansNutsMedicineFood scienceChildDental Restoration PermanentSugareducationGeneral Dentistryeducation.field_of_studyDMF Indexbusiness.industrydigestive oral and skin physiologyfood and beveragesStarchBreadFeeding BehaviorArtificial SweetenerCariostatic AgentsCross-Sectional StudiesSpainFruitChild populationFood processingFemaleDairy ProductsbusinessCaries experienceToothpastesCaries Research
researchProduct

Towards the potential use of (1)H NMR spectroscopy in urine samples for prostate cancer detection

2014

A simple method based in multivariate analysis of 1H NMR spectra profiles of urine samples can be used to detect patients with prostate cancer.

MaleUrine samples1h nmr spectroscopyMagnetic Resonance SpectroscopyPerformanceAnalytical chemistryUrineUrinalysisBiochemistryAnalytical ChemistryProstate cancerMetabolomicsValidationElectrochemistrymedicineSecretionsHumansEnvironmental ChemistryMetabolomicsPROYECTOS DE INGENIERIASpectroscopyChromatographyProstate cancerChemistryfungiQUIMICA INORGANICAProstateProstatic Neoplasmsfood and beverages1H NMRmedicine.diseaseTissuesMultivariate analysisProton NMR
researchProduct

The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemother…

2017

Background: The Khorana score is a predictive risk model for venous thromboembolism (VTE) in patients with cancer planning to receive chemotherapy. Urothelial carcinoma and variant histologies (UC/VH) were underrepresented in the model. We sought to evaluate whether the Khorana score predicts for VTE in a retrospective multinational data set of patients with metastatic UC/VH. Methods: Patients diagnosed with metastatic UC/VH who received chemotherapy were eligible. Those with incomplete or miscoded data were excluded. Khorana scores were calculated based on the pretreatment data and categorized into high (≥3) or intermediate (1-2) VTE risk. Other patient-, tumor-, and therapy-related factor…

MaleUrologic Neoplasmsmedicine.medical_specialtyMetastatic Urothelial Carcinomamedicine.medical_treatmentvenous thromboembolismAntineoplastic AgentsKhorana score030204 cardiovascular system & hematologyUrologic NeoplasmschemotherapyGastroenterologyArticleLeukocyte Count03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPredictive Value of TestsRisk FactorsInternal medicinemedicineHumanscardiovascular diseasesLeukocytosisNeoplasm MetastasisAgedRetrospective StudiesChemotherapyBladder cancerbusiness.industryCancerRetrospective cohort studyHematologyGeneral MedicineMiddle Agedequipment and suppliesmedicine.disease3. Good healthSurgeryleukocytosisCardiovascular Diseases030220 oncology & carcinogenesisPredictive value of testsbladder cancerFemaleUrotheliummedicine.symptombusinessClinical and Applied Thrombosis/Hemostasis
researchProduct

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

2019

<b><i>Introduction:</i></b> Androgen receptor variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC) and has shown potential as a predictive biomarker in circulating tumour cells (CTCs) isolated from the bloodstream in terms of a liquid biopsy. Studies have shown that AR-V7 is a potential surrogate for selecting drug classes for systemic treatment by detecting nuclear AR-V7 by immunofluorescence or measuring AR-V7 messenger RNA by quantitative PCR. Here, we assessed the predictive value of AR-V7 detected by classical immunohistochemistry (IHC) for treatment response. <b><i>Methods:</i></b> C…

MaleUrology030232 urology & nephrologyAntineoplastic AgentsDocetaxel03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineCell Line TumormedicineHumansEnzalutamideProspective StudiesLiquid biopsyAgedAged 80 and overbusiness.industryAndrogen AntagonistsNeoplastic Cells CirculatingPrognosismedicine.diseaseAndrogen receptorProstatic Neoplasms Castration-ResistantTreatment OutcomeDocetaxelchemistryReceptors AndrogenCabazitaxel030220 oncology & carcinogenesisCancer researchBiomarker (medicine)ImmunohistochemistryTaxoidsbusinessmedicine.drugUrologia Internationalis
researchProduct

The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.

2018

Prostate-specific membrane antigen (PSMA) is a transmembrane protein with significantly increased expression in the cells and metastases of prostate carcinoma (CaP). PSMA-expression correlates with higher serum levels of prostate-specific antigen (PSA) and a higher Gleason score (GS). This finding has led to the development of novel imaging modalities such as 68Ga-/18F-labeled PSMA positron emission tomography/computed tomography (PET/CT) and positron emission tomography/magnetic resonance imaging (PET/MRI). This article reviews the literature pertaining to various new imaging technologies for the management of CaP. PSMA positron emission tomography/computed tomography appears to be an exce…

MaleUrology030232 urology & nephrologyComputed tomographyGallium Radioisotopesurologic and male genital diseasesMultimodal ImagingManagement of prostate cancer03 medical and health sciences0302 clinical medicinePositron Emission Tomography Computed TomographymedicineOrganometallic CompoundsHumansGallium IsotopesMembrane antigenSalvage TherapyPET-CTMembrane Glycoproteinsmedicine.diagnostic_testbusiness.industry68ga psmaProstatic NeoplasmsMagnetic resonance imagingProstate carcinomaProstate-Specific AntigenMagnetic Resonance ImagingPositron emission tomography030220 oncology & carcinogenesisPositron-Emission TomographyNeoplasm Recurrence LocalRadiopharmaceuticalsbusinessNuclear medicineUrology
researchProduct

Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparame…

2020

OBJECTIVE. The purpose of this study was to evaluate in a multicenter dataset the performance of an artificial intelligence (AI) detection system with attention mapping compared with multiparametric MRI (mpMRI) interpretation in the detection of prostate cancer. MATERIALS AND METHODS. MRI examinations from five institutions were included in this study and were evaluated by nine readers. In the first round, readers evaluated mpMRI studies using the Prostate Imaging Reporting and Data System version 2. After 4 weeks, images were again presented to readers along with the AI-based detection system output. Readers accepted or rejected lesions within four AI-generated attention map boxes. Additio…

MaleUrologyAdenocarcinomaSensitivity and SpecificityArticle030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerRandom Allocation0302 clinical medicineLaparoscopicProstateArtificial IntelligenceStatistical significanceMedicineHumansAttentionRadiology Nuclear Medicine and imagingDiagnosis Computer-AssistedMultiparametric Magnetic Resonance ImagingAgedRetrospective StudiesObserver VariationProstate cancerbusiness.industryartificial intelligence; laparoscopic; MRI; multiparametric; prostate cancer; radical prostatectomy; robot-assistedSignificant differenceCancerMultiparametric MRIProstatic NeoplasmsGeneral MedicineRobot-assistedMiddle Agedmedicine.diseaseRadical prostatectomymedicine.anatomical_structure030220 oncology & carcinogenesisMapping systemMultiparametricArtificial intelligencebusinessAlgorithmsMriAJR. American journal of roentgenology
researchProduct

ProstateAnalyzer: web-based medical application for the management of prostate cancer using multiparametric MR imaging

2016

Objectives: In this paper, we present ProstateAnalyzer, a new web-based medical tool for prostate cancer diagnosis. ProstateAnalyzer allows the visualization and analysis of magnetic resonance images (MRI) in a single framework. Methods: ProstateAnalyzer recovers the data from a PACS server and displays all the associated MRI images in the same framework, usually consisting of 3D T2-weighted imaging for anatomy, dynamic contrast-enhanced MRI for perfusion, diffusion-weighted imaging in the form of an apparent diffusion coefficient (ADC) map and MR Spectroscopy. ProstateAnalyzer allows annotating regions of interest in a sequence and propagates them to the others. Results: From a representat…

Male[ SDV.MHEP.UN ] Life Sciences [q-bio]/Human health and pathology/Urology and NephrologyNursing (miscellaneous)Computer scienceBiopsycomputer.software_genre[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology[ SDV.CAN ] Life Sciences [q-bio]/CancerSoftwareSegmentationHealth Information ManagementMagnetic-ResonanceProstate -- Cancer -- ImagingDiagnosisContrast-Enhanced Mrimagnetic resonance imagingSegmentationComputingMilieux_MISCELLANEOUSSpectroscopyPròstata -- Càncermedicine.diagnostic_test[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingProstate--Cancerprostate cancer3. Good healthdatabase management systemData miningImaging systems in medicinemedicine.medical_specialtyapplicationsScoring SystemHealth Informatics[SDV.CAN]Life Sciences [q-bio]/Cancer:Enginyeria dels materials [Àrees temàtiques de la UPC]Set (abstract data type)Software portabilityImatges per ressonància magnètica[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyImage Interpretation Computer-AssistedUltrasoundmedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingWeb applicationHumansmedical informaticsMedical physicsJava appletPròstata -- Càncer -- ImatgesInternetbusiness.industryProstatic NeoplasmsMagnetic resonance imagingmagnetic resonance spectroscopyVisualizationLocalizationImagesImatgeria mèdicabusinesscomputer[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxe…

2010

There is currently no standard of treatment for patients with hormone refractory prostate cancer (HRPC) after failure of docetaxel-based chemotherapy. The purpose of this study was to assess the anticancer activity and tolerance of metronomic cyclophosphamide prednisolone combination in this setting.From 2005 to 2010, patients with HRPC who failed at least docetaxel-based chemotherapy were proposed metronomic cyclophosphamide-prednisolone regimen, and were prospectively registered. Twenty-three patients received 50 mg cyclophosphamide and 10 mg prednisolone per os daily until disease progression. Treatment tolerance and efficacy on PSA decrease and pain were studied.Metronomic cyclophospham…

Male[SDV.IMM] Life Sciences [q-bio]/ImmunologyMESH : Antineoplastic Combined Chemotherapy ProtocolsMESH: Treatment FailurePrednisoloneMESH : MaleMESH : PrednisoloneMESH: TaxoidsMESH : AgedMESH : Prospective StudiesDocetaxelMESH : Treatment OutcomeMESH : Treatment FailureMESH: Aged 80 and overAntineoplastic Combined Chemotherapy ProtocolsHumans[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyMESH : Middle AgedProspective StudiesTreatment FailureMESH : Prostate-Specific AntigenMESH : Aged 80 and overMESH : TaxoidsCyclophosphamideMESH : Cyclophosphamidehealth care economics and organizationsAgedMESH: Treatment OutcomeAged 80 and overMESH: AgedMESH: HumansMESH: Middle AgedMESH : HumansProstatic NeoplasmsMESH: CyclophosphamideMiddle AgedProstate-Specific AntigenMESH: MaleMESH: Prospective StudiesMESH: Prostate-Specific AntigenMESH: Antineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeMESH: Prostatic Neoplasms[SDV.IMM]Life Sciences [q-bio]/ImmunologyTaxoidsMESH: PrednisoloneMESH : Prostatic Neoplasms
researchProduct

MI paste plus and PreviDent fluoride varnish appear no more effective than normal home care for improving the appearance of white spot lesions.

2013

Article Title and Bibliographic Information Effectiveness of MI Paste Plus and PreviDent fluoride varnish for treatment of white spot lesions: a randomized controlled trial. Huang GJ, Roloff-Chiang B, Mills BE, Shalchi S, Spiekerman C, Korpak AM, Starrett JL, Greenlee GM, Drangsholt RJ, Matunas JC. Am J Orthod Dentofacial Orthop 2013;143:31-41. Reviewer Carmen Llena-Puy Purpose/Question The authors' aim was to compare the effectiveness of MI Paste Plus and PreviDent fluoride varnish (22,600 ppm of fluoride) with a standard oral hygiene regimen with toothpaste (1100 ppm of fluoride; Colgate Oral Pharmaceuticals)--control group--in improving the appearance of white spot lesions (WSLs) after o…

Malebusiness.product_categoryDentistryDental CariesOral hygieneArticlelaw.inventionBibliographic informationchemistry.chemical_compoundRandomized controlled triallawMedicineHumansFluorides TopicalGeneral DentistryToothpastebusiness.industryFluoride varnishCaseinsFluorineCariostatic AgentsRegimenchemistryFemalebusinessFluorideThe journal of evidence-based dental practice
researchProduct